Literature DB >> 18986416

Evaluation of the left ventricular function with tissue tracking and tissue Doppler echocardiography in pediatric malignancy survivors after anthracycline therapy.

Cemşit Karakurt1, Gulendam Koçak, Unsal Ozgen.   

Abstract

Although the anthracyclines have gained widespread use in the treatment of childhood hematological malignancies and solid tumors, cardiotoxicity is the major limiting factor in the use of anthracyclines. The aim of this study was to assess the mitral annular displacement by tissue tracking in pediatric malignancy survivors who had been treated with anthracycline groups chemotheraphy and compare with the tissue Doppler and conventional two dimensional measurements and Doppler indices.In this study, 32 pediatric malignancy survivors and 22 healthy children were assessed with 2D, colour-coded echocardiography. Left ventricular ejection fraction, fractional shortening, stroke volume, cardiac output, cardiac index and diastolic functions were measured. All subjects were assessed with tissue Doppler echocardiography, mitral annular displacements, and also with tissue tracking method.We detected that peak velocity of the early rapid filling on tissue Doppler (E') was lower (p < 0.05) and the ratio of early peak velocity of rapid filling on pulse Doppler to tissue Doppler (E/E') values were statistically higher in patient group than control group (p < 0.05). Myocardial performance index values were also higher in patient group than the control group (p < 0.01). It appears that MPI is a useful echocardiograghic method than tissue tracking of mitral annular displacement in patients with pediatric cancer survivors who had subclinical diastolic dysfunction.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18986416     DOI: 10.1111/j.1540-8175.2008.00695.x

Source DB:  PubMed          Journal:  Echocardiography        ISSN: 0742-2822            Impact factor:   1.724


  17 in total

1.  Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging.

Authors:  Juan Carlos Plana; Maurizio Galderisi; Ana Barac; Michael S Ewer; Bonnie Ky; Marielle Scherrer-Crosbie; Javier Ganame; Igal A Sebag; Deborah A Agler; Luigi P Badano; Jose Banchs; Daniela Cardinale; Joseph Carver; Manuel Cerqueira; Jeanne M DeCara; Thor Edvardsen; Scott D Flamm; Thomas Force; Brian P Griffin; Guy Jerusalem; Jennifer E Liu; Andreia Magalhães; Thomas Marwick; Liza Y Sanchez; Rosa Sicari; Hector R Villarraga; Patrizio Lancellotti
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2014-10       Impact factor: 6.875

2.  Evaluation of traditional and novel measures of cardiac function to detect anthracycline-induced cardiotoxicity in survivors of childhood cancer.

Authors:  Andrew C Dietz; Shanthi Sivanandam; Suma Konety; Christopher L Kaufman; Ryan M Gage; Aaron S Kelly; Joseph P Neglia; Daniel A Mulrooney
Journal:  J Cancer Surviv       Date:  2013-12-07       Impact factor: 4.442

3.  Assessment of early-onset chronic progressive anthracycline cardiotoxicity in children: different response patterns of right and left ventricles.

Authors:  Abdullah Kocabaş; Fırat Kardelen; Halil Ertuğ; Bilge Aldemir-Kocabaş; Özgür Tosun; Akif Yeşilipek; Volkan Hazar; Gayaz Akçurin
Journal:  Pediatr Cardiol       Date:  2013-07-03       Impact factor: 1.655

Review 4.  Managing chemotherapy-related cardiotoxicity in survivors of childhood cancers.

Authors:  Steven E Lipshultz; Melissa B Diamond; Vivian I Franco; Sanjeev Aggarwal; Kasey Leger; Maria Verônica Santos; Stephen E Sallan; Eric J Chow
Journal:  Paediatr Drugs       Date:  2014-10       Impact factor: 3.022

5.  Screening for cardiomyopathy in muscular dystrophy with tissue doppler imaging.

Authors:  Rachna Seth; Sandeep Seth; Veena Kalra
Journal:  Indian J Pediatr       Date:  2010-04-17       Impact factor: 1.967

6.  Evaluation of cardiotoxicity by tissue Doppler imaging in childhood leukemia survivors treated with low-dose anthracycline.

Authors:  Cengiz Bayram; İlker Çetin; Betul Tavil; Nese Yarali; Filiz Ekici; Pamir Isık; Bahattin Tunc
Journal:  Pediatr Cardiol       Date:  2015-01-11       Impact factor: 1.655

7.  Cardiac complications of chemotherapy: role of imaging.

Authors:  Timothy C Tan; Marielle Scherrer-Crosbie
Journal:  Curr Treat Options Cardiovasc Med       Date:  2014-04

8.  Screening for cardiac dysfunction in anthracycline-exposed childhood cancer survivors.

Authors:  Saro H Armenian; Sarah K Gelehrter; Tabitha Vase; Rajkumar Venkatramani; Wendy Landier; Karla D Wilson; Claudia Herrera; Leah Reichman; John-David Menteer; Leo Mascarenhas; David R Freyer; Kalyanasundaram Venkataraman; Smita Bhatia
Journal:  Clin Cancer Res       Date:  2014-06-19       Impact factor: 12.531

9.  Use of speckle tracking in the evaluation of late subclinical myocardial damage in survivors of childhood acute leukaemia.

Authors:  Elena Guadalupe Corella Aznar; Ariadna Ayerza Casas; Lorenzo Jiménez Montañés; Maria Ángeles Carlota Calvo Escribano; José Ignacio Labarta Aizpún; Pilar Samper Villagrasa
Journal:  Int J Cardiovasc Imaging       Date:  2018-04-02       Impact factor: 2.357

Review 10.  Cancer treatment-related cardiac toxicity: prevention, assessment and management.

Authors:  Ibrahim Fanous; Patrick Dillon
Journal:  Med Oncol       Date:  2016-07-02       Impact factor: 3.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.